Phase 2 Leishmaniasis Clinical Trials

7 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–7 of 7 trials

Recruiting

Phase 2

Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis

Cutaneous Leishmaniasis

Hayder Adnan Fawzi40 enrolled1 locationNCT06797544

Recruiting

Phase 2

Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

Cutaneous Leishmaniasis

Al-Mustafa University College80 enrolled1 locationNCT06798402

Recruiting

Phase 2

Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine

Mucosal Leishmaniasis

Fundacion Nacional de Dermatologia30 enrolled1 locationNCT06550609

Recruiting

Phase 2

Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis

Cutaneous Leishmaniasis

Hayder Adnan Fawzi40 enrolled1 locationNCT06798415

Recruiting

Phase 2Phase 3

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

Leishmaniasis, MucocutaneousLeishmaniasis; Brazilian

University of Brasilia100 enrolled1 locationNCT06040489

Completed

Phase 2Phase 3

Liposomal amphotericin B for the treatment of Nepalese patients with visceral leishmaniasis.

Visceral Leishmaniasis

The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35 enrolled1 locationACTRN12610000130066

Active

Phase 2Phase 3

Liposomal amphotericin B for the treatment of Bangladeshi patients with visceral leishmaniasis.

Visceral leishmaniasis (VL)